Literature DB >> 2783421

Structural significance of the C-terminal amphiphilic helix of interleukin-2.

B Landgraf1, F E Cohen, K A Smith, R Gadski, T L Ciardelli.   

Abstract

The structural significance of C-terminal amphiphilic alpha-helix of human interleukin-2 has been investigated using principles of protein design. Employing disulfide-mediated semi-synthesis, several multiple residue substitution patterns were studied in order to provide rapid insight into the most appropriate features to incorporate into fully recombinant proteins. Substitutions directed toward both stabilization and destabilization of the helix resulted in proteins with modulated bioactivity. Circular dichroism verified the conformational integrity and thermal stability of the derivatives. The biologic characteristics of each derivative were evaluated in the standard murine CTLL-2 assay and compared to activities exhibited in both human T-cell bioactivity and binding assay. A strategy for the design of protein ligand agonists and antagonists without knowledge of receptor contact residues is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783421

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Irreversible inactivation of interleukin 2 in a pump-based delivery environment.

Authors:  S T Tzannis; W J Hrushesky; P A Wood; T M Przybycien
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

2.  Insufficient (sub-native) helix content in soluble/solid aggregates of recombinant and engineered forms of IL-2 throws light on how aggregated IL-2 is biologically active.

Authors:  Uzma Fatima; Balvinder Singh; Karthikeyan Subramanian; Purnananda Guptasarma
Journal:  Protein J       Date:  2012-10       Impact factor: 2.371

3.  Use of site-directed mutagenesis to enhance the epitope-shielding effect of covalent modification of proteins with polyethylene glycol.

Authors:  M S Hershfield; S Chaffee; L Koro-Johnson; A Mary; A A Smith; S A Short
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Modification of Escherichia coli B glutathione synthetase with polyethylene glycol for clinical application to enzyme replacement therapy for glutathione deficiency.

Authors:  Y Inoue; K Sugiyama; H Ueminami; S Izawa; A Kimura
Journal:  Clin Diagn Lab Immunol       Date:  1996-11

5.  Partial agonist/antagonist mouse interleukin-2 proteins indicate that a third component of the receptor complex functions in signal transduction.

Authors:  S M Zurawski; J L Imler; G Zurawski
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

6.  A detailed map of coupled circadian clock and cell cycle with qualitative dynamics validation.

Authors:  Adrien Rougny; Loïc Paulevé; Michèle Teboul; Franck Delaunay
Journal:  BMC Bioinformatics       Date:  2021-05-11       Impact factor: 3.169

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.